
|Articles|December 18, 2012
GAO Push for Lower Dialysis Bundle Spurs Controversy
Advertisement
Dialysis and kidney-care providers are taking issue with a Government Accountability Office report released this month that found the government may be over-paying for end-stage renal disease treatment.
The report called on the CMS to re-examine the amount it's paying (PDF) for dialysis care, arguing that the agency bases its bundled payment rates on 5-year-old drug utilization trends that are no longer current.
It added that if the payments accurately reflected current prescribing trends for end-stage renal disease, Medicare would have saved at least $650 million in 2011, up to as much as $880 million—and that those savings are only forecasted to grow.
Read the full story:
Source: ModernHealthcare.com
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
ACO-SWITCH to Evaluate Tafamidis-to-Acoramidis Switch in ATTR-CM
3
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
4
Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk
5




